Join Us At EACR 2025!

EditCo Sponsored Industry Symposium

Title: Uncovering Novel Cancer Therapeutic Targets: Accelerating Discovery Through Streamlined CRISPR Cell Engineering

This symposium will feature thought leaders in molecular oncology, gene editing, and computational biology, highlighting how CRISPR technologies are transforming cancer research.

Session Overview:

• Dr. Simon Lebaron, Centre de Biologie Intégrative, University of Toulouse
  Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

  Related Case Study:

  Rapid, Reliable Knockouts for Cancer Biology with XDel Technology: Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic Target

• Dr. Daniel Miller, Evariste
  AI-Driven Identification and Validation of Novel Synthetic Lethal Gene Pairs

• Dr. Amalia Soenens, EditCo Bio
  Leveraging an Advanced CRISPR Platform to Streamline Oncology Breakthroughs

Our team will be available to discuss custom cell line engineering, CRISPR screening services, and how EditCo can support your next oncology-focused study.

Featured Poster Presentation

Title: HiBiT-Tagged CRISPR Cell Line Engineering: Enabling Antibody-Free Protein Quantification and Targeted Degradation Analysis in Cancer Research

Session: Cancer Cell Biology

Date: June 18, 2025

Time: 10:45 – 20:00

Stop by to learn how our HiBiT knock-in cell line service enables highly sensitive, real-time protein monitoring—ideal for functional genomics, targeted protein degradation, and other cancer research applications.